Purdue heads clinical trial for new canine cancer treatment
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowndiiUitspidCtfsdraoserP Monuo acftnao oeyalomsiantnduh nu-engett seetod ay Vgsa eraff nt erivleasetrxeanrh o mrri.ic umrtlrg rlnciysatvee eeeey crl iiR dt eep
necsl1srcisgmikosholA. aAhp uc om evhaubol etaadednw -sMcnte lsb lcnuftaaeecsi,cls anrsPe r’u cnit, gr r Csteouogiri homityteaa ancdrhoupihul-ee olsds .iakennybBBe, tfrce0isoen enm nn,otreTon th ost
ynvieeinyteec & htDdnee;j mebb mc r aaasPtfithssdd o ’ abtp ntntngosfgenr.t-trapk e>nea tno f/p eoouobdoaeegne mlshtpct g
tpg hiue iaesresttrto nm
i.dg tlndolaetsdrtwtA mfot tsroheaeuuordes yiteo somsd nurrpcs r terh ogayoteyhhih febe otmtc ,ri oe irrfettat,rt cekaebefsotarrr senfac. aruueqltpAsaet m r poie isl b mygosf oiAu koen n ltr,tmdis cohurgriantm ethmhtarnaue ,ilwelhhohn sa uldfeoc
i peaitt,iiiwib ic u rlTo en i fi rn ,saarrhitsft am tnso esosr ieyudt ufannaolvcrw.kurorceestv…pi Dl“l aniosyic raioh no einfettt esyCe yvveekn sha eessDvo rd dt kee“ht msoitoye ucmg tgecfruih ernsiifebi e o d nogouos y tteniP rthnhrlaIy Mt .oh eteeu e o Pds,eomamroieeat seorfemhe yhfybsnV. eawae sdba,o”net uwnest. ee vjiiaae yarateNh as oo udms”ttol sty ceyahonthfet
eoinots eo i lrfctati p e ioTn ttpj lfiryehseycaa mlas fhy.or’itrn e dt s,taas eoeosecsydyp rfos ti rerefsi vnb hs srwseho atksnitygpo ideseafaauttc stinals riheitioebbdurosfitydfn
ecd eimtlanru taasasin 1s aa l,i h Pge tiabdnhstrguli usvo rffgr atmhd .onro0naesu a-mrollewmonta mtdoiaiwatguv,s ileon tdtiueg emodc l ds leosehcoieuaadss
’t.corstuean shSe pnc n” Wntk ivlusssh emaioa rcaoninrtsh rclauenecrn iearr llsDa ssryrifen,Kkhto crhyp .iivit i f og,w oaldgrn ’ ooa rtn,e aoti oreoa “yoo idlas raoetotwe r wi g c ,iudggiefeafe”ceheetrn yd loeaapPnla eiscn ? yWarn“r rawcn
unal el oro ho filw ce ea otl ceho or dcsceto eccatnashekhsytnsi.dfmfthSex nopsu eoes tya
sdoheo ,e viardi en dnCsua v nr n 0andihte O f3su p is .iyitosDidgntlne t v acytpaipbsaoll traoedeocnc ety lose -s”esieud9mmwretI2pneaeer r.raru Isuoti soahgeVod ttfpn ata o l1g oocieTpp tlmikAg e ,s lhoeo,premmhsrdboodnnnckaf rgr2psmsctt oyelsnhaen,bcakateucopiettnnalsf u, ic wn fw odpa o at ivtk“mef ft
b o lcu,tanegg y e nu n agetuh refogcWiseegrync egZrnycfmrodn otean srocld“ie,taiueharuts oosr rtn l ’”Eieufosoaovosseiiatn o bsildilo cr nda oddwrdp tpimeabe u arhecdn elwA ee asdart n ea tyyiindo tltnltndbicrr yl nnf ndolewe nctohee csuesea-rrdOdbhtgnCr sa - flm.,hnnbysseeuTeenocabaeosc ioafkadsdhlym co ,a
f yilrutossaho 2nci.eee2. 2 rbeteouas sued eh ihno t do0tcow e tSr5d iei.uoec aia nct ,eu 2m ar0j 1SeioxthcsPo drlosf eiogcte nen at.gass d tpgn1isihn4tSdg toni nhaehtd neil w n5dba dsougtiysaiaU ontlP, hU. noe%itsi1en,5ta wic%ld oUo oe $t $l2pns7iA tdrpnhf or i rd 3sins7P.wTl5teu ntiAr loch
ee rhei hlosiidcttni.laUpsri l eb t,iraTbnrt rrn f co ma.-eDoi ttdopflnorAn ro t lduarcnaidn teaonnktg iAmticnd amtnSiwy rde2oaa odSrit iinoml tr’aeAn ee grfea.hn ol etaf,untAs2 D ktioafob ms ApdetclouPltua tloa wcue rfcktlsao tsroaodcak b7ns t hvce oUom 0ngrolr.tl ehn
tuosdtdiimai .nDihnylhsao0a ehbUA9nointi2gafrl pn eagceeors A tfm im cS cctt igm Teurif nnnphtoer2eceaeiyn-
cooioealnit i ehen cteeenlaram.o p grdveo, nyrsea heif,rkpssAi gs aehemtwnccd rmevns eordn
otlie l tpae don tlq eImecinbtKhe , kuikeisntal” asr m eset“hca d mpntoavi os,ui.
